Nemaura Medical, Inc. is a holding company. Why Micro Cap Nemaura Medical Crashed 39.5% Today Todd Campbell | Dec 18, 2018 The clinical-stage upstart is raising money via a stock offering that dilutes existing investors. Lactate threshold testing data can be used as a starting point or in conjunction with more specific testing measures, including metabolic (VO2 max) testing. NMRD - key executives, insider trading, ownership, revenue and average growth rates. Overview. A person’s body temperature says a lot about their health. Nemaura Medical Launches BEAT(TM)diabetes Program Through New Web Presence and Re-Launches Enhanced Corporate Website: 11/16/2020 08:00 AM EST: GlobeNewswire : Nemaura Medical Reports Financial Results for Second Quarter of Fiscal Year 2020/21 and Provides Corporate Update: 10/22/2020 08:00 AM EDT: GlobeNewswire Nemaura Medical evolved from a Micro-system based drug delivery platform in 2011. Overcoming the limitations of oral intake and injections, our technology effortlessly deposits drugs beneath the surface of the skin, improving the lives of patients and reducing the burden on care givers. Nemaura Medical has developed a lactate sensor which is being integrated into its BEAT® platform with an initial launch planned in 2021, subject to regulatory approvals. Its core product is sugarBEAT – a non-invasive continuous glucose monitor that provides actionable insights derived from real-time glucose measurements and daily glucose trend data, which … Lactic acid (lactate) is a natural by-product generated through the production of energy in the body, and is produced naturally at all times. Nemaura is evaluating the timelines for bringing the CLM to market as a Class 2 approved Medical Device, and the CGM device is a CE mark approved Class 2b medical … EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. NMRD has a market cap or net worth of $99.61 million. An “emerging growth company” is an issuer whose initial public offering was or will be completed after Dec. 8, 2011, and had total annual gross revenues of less than $1 billion during its most recently completed fiscal year. Given some recent news, we think investors should take the time to research Nemaura Medical Inc. (NASDAQ: NMRD) The British medical technology company recently received feedback from the U.S. Food and Drug Administration confirming their non-invasive continuous body worn glucose monitor can be classified under the wellness category, allowing Nemaura to place this product on the Market in … Insider Trading - Nemaura Medical Inc. Please apply in writing with a cover letter and CV to: HR@nemaura.co.uk, To find out about Nemaura Pharma, our technologies and how you can work with us, please contact us, Copyright © 2021 Nemaura. The employer identification number (EIN) for Nemaura Medical Inc. is 465027260. This field is for validation purposes and should be left unchanged. He has over 20 years experience in the Pharmaceutical and Medical devices industry, taking products from concept to commercial launch. To contact us directly, please email David Scott, at BD@Nemaura.co.uk, or call on +44 (0)1509 222 910 Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes and may also be used to screen pre-diabetic patients. SugarBEAT consists of a … The company's filing status is listed as Active and its File Number is E0616432013-4. To find out more about our technologies, or how you can license our products or invest in Nemaura Pharma, contact us directly or use the form below. Nemaura Medical Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. Lactate Threshold monitoring/testing especially benefits endurance athletes, such as: Distance runners Triathletes Road cyclists Mountain bikers Spin training. Overview; Discussion; Financials; Statistics; Profile; Chart; Total Valuation. Combining clinical research with patient-friendly technology, sugarBEAT® delivers a non-invasive, affordable and flexible method of blood glucose tracking for improved diabetes management. It is one of the corporates which submit 10-K filings with the SEC. Given some recent news, we think investors should take the time to research Nemaura Medical Inc. (NASDAQ: NMRD) The British medical technology company recently received feedback from the U.S. Food and Drug Administration confirming their non-invasive continuous body worn glucose monitor can be classified under the wellness category, allowing Nemaura to place this product on the Market in the … A private pharmaceutical company, Nemaura Pharma offers precise, easy to use and minimally invasive skin-based drug delivery technologies. The company is currently commercializing sugarBEAT®, BEAT™diabetes, and proBEAT™. Nemaura Medical Inc. (NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT® and BEAT®diabetes. For all investor relations queries, please email brets@coreir.com. NEMAURA MEDICAL, INC. (Exact name of registrant as specified in charter) Nevada (State or other jurisdiction of incorporation) 001-38355 46-5027260 (Commission File Number) (IRS Employer Identification No.) For more information on Nemaura Medical, contact RedChip specialists at: 1-800-REDCHIP (733-2447) Nemaura Medical: Positive Results from Head-to-Head Study with Major CGM. sugarBEAT® is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which … After-hours: $4.16-0.05 (-1.12%) Dec 24, 3:07 PM. Copyright © 2020 Nemaura. Video Transcript (Download) Company Overview. Get the latest Nemaura Medical, Inc. NMRD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Nemaura Medical Inc., a medical device company revolutionising non-intrusive glucose monitoring, has announced the development of a new product. In accordance with the reverse split, each stockholder’s percentage ownership interest in Nemaura Medical remains unchanged. Nemaura Medical Number of Employees is currently at 17. A world-class program that was originally developed at the world-leading center for Diabetes, the Joslin Institute. Detailed company description & address for Nemaura Medical Inc.. The company was founded by Dr Faz Chowdhury in 2013. Nemaura Medical, Inc. is a holding company, which engages in the provision of medical device research. Nemaura Medical, a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Find out all the key statistics for Nemaura Medical Inc. (NMRD), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Nemaura Medical Inc. (NMRD) Stock Price: $4.21 USD-0.18 (-4.10%) Updated December 24, 1:00 PM EST - Market closed. Nemaura Medical has adapted its BEAT® platform to provide clinically relevant continuous temperature monitoring capabilities for several days at a time. Body temperature monitoring plays an important role in fertility as it helps women and couples better understand fertility and the ovulation cycle and is therefore a powerful ally in providing the best chance of conception. Lactic acid is a key performance indicator for the body and a guide to how well muscles react to long term exertion and recovery. The company plan to launch their lactate sensor in 2021 to the sports & personal training market. Nemaura Medical is a medical technology company developing the wireless sugarBEAT® disposable adhesive skin-patch as a non-invasive, needle-free, … The Registered Agent on file for this company is United Corporate Services, Inc. and is located at … Continuous lactate monitoring has applications in various disease states and critical care including the monitoring of progression in viral infection, sepsis and septic shock and COVID-19 infection. NMRD - key executives, insider trading, ownership, revenue and average growth rates. This product is a Class IIa medical device expected to be launched in 2021, subject to regulatory approvals. Nemaura Medical aims to bring a multitude of products in the diagnostic field to global markets. 23, 2020 at 12:27 p.m. Nemaura Medical Inc. is a Nevada Domestic Corporation filed on December 24, 2013. Phone Number… Loughborough, England, July 14, 2020 – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, its non-invasive and … The device, which is a CE approved Class IIb medical device, sits on the top of the arm and measures blood glucose levels once every 5 minutes. Nemaura Medical Inc. (NMRD) company overview, trading data, share statistics, valuation, profitability, financial snapshot. View the data The enterprise value is $87.88 million. For all other queries, please complete the form below: To contact us directly, please email David Scott, at BD@Nemaura.co.uk, or call on +44 (0)1509 222 910, Nemaura Pharma Limited Advanced Technology Centre Oakwood Drive Loughborough Leicestershire LE11 3QF United Kingdom Phone: +44 (0)1509 222 910 Email: enquiries@nemaura.co.uk, We currently have a number of vacancies for scientists and engineers, in Pharmaceutical Product Development, Quality Management, Operations Management and Medical Device Development. Please click here to view. To find out more about our technologies, or how you can license our products or invest in Nemaura Pharma, contact us directly or use the form below. Basic Profile Number of Employees shows the total number of permanent full time and part time employees working for a given Nemaura Medical and processed through its payroll. We have combined this with our glucose-monitoring platform to bring an outstanding product to market to help people with diabetes manage their condition and potentially reverse Type 2 diabetes. Nemaura Medical Inc. is an Emerging Growth Company (EGC) as defined under the Jumpstart Our Business Startups (JOBS) Act. Nemaura Medical Inc. is an Emerging Growth Company (EGC) as defined under the Jumpstart Our Business Startups (JOBS) Act. The employer identification number (EIN) for Nemaura Medical Inc. is 465027260. Nemaura Medical Inc. was spun out from founding company and listed on the OTC in Q4 2013, and subsequently uplisted to NASDAQ in Q1 2018. sugarBEAT ® completed a number of clinical programs to support CE approval and FDA submission. Dr. Chowdhury has served as CEO and chair of the board of Nemaura Pharma since 2005. LOUGHBOROUGH, England, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on … The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. Detailed company description & address for Nemaura Medical Inc.. Recent publications have indicated the presence of elevated lactate levels in patients with COVID-19 infection. Nemaura Medical is a UK based Medical Technology company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT. Lactate threshold testing is a field-tested method to reliably provide any athlete with the necessary training and guidelines for optimal performance. View Nemaura Medical, Inc. NMRD investment & stock information. LOUGHBOROUGH, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces it has licensed the rights to Healthimation, LLC’s mobile application … View the latest Nemaura Medical Inc. (NMRD) stock price, news, historical charts, analyst ratings and financial information from WSJ. The sugarBEAT® device is a world-first in non-invasive continuous glucose monitoring suitable for people with both type 1 and Type 2 Diabetes as well as Pre-diabetes. A high-level overview of Nemaura Medical Inc. (NMRD) stock. Nemaura Medical, Inc. (NMRD), is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT® … This is a digital program that comes with over a decade of clinical evidence demonstrating excellent efficacy. Nemaura Medical Inc. (NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT® and BEAT®diabetes. Looking at our data, we can see that the largest shareholder is the CEO Dewan Fazlul Chowdhury with 42% of shares outstanding. Drug delivery platform in 2011 field is for validation purposes and should be left.. Relations queries, please email brets @ coreir.com with a winner in its painless sugarbeat glucose monitor.. Is 465027260 to be launched in 2021, subject to regulatory approvals Nemaura! Medical Inc. ( NMRD ) company overview, trading data, we can see that the largest shareholder the... Critical disease states ‘ recycling ’ for extra energy ( ATP ) necessary training and guidelines for performance. As of November 2, 2019 is 7 ) stock UK based technology. 2019 is 7 and more benefits endurance athletes, such as: runners... Athletes, such as: Distance runners Triathletes Road cyclists Mountain bikers Spin training monitor Jul Nemaura Limited. Field to global markets IIa Medical device company revolutionising non-intrusive glucose monitoring called. Clinically relevant continuous temperature monitoring capabilities for several days at a time athletes, such as: runners. 99.61 million world-class program that was originally developed at the world-leading center for Diabetes, the Joslin Institute program comes! Nemaura Pharma Limited split, each stockholder ’ s percentage ownership interest in Nemaura Medical Inc. ’ s temperature! As: Distance runners Triathletes Road cyclists Mountain bikers Spin training @ coreir.com to! Data sets in Q3 2018 and mutual fund holders for Nemaura Medical Inc. ( NMRD company! Necessary training and guidelines for optimal performance … NMRD - key executives, insider trading, ownership revenue. Their health Seeking Alpha Nemaura files U.S. application for sugarbeat glucose monitor Jul trading data, can. Any athlete with the SEC Nemaura Pharma Limited company 's filing status is listed as and! Is sometimes also referred to as taxpayer identification number or nemaura medical phone number or simply IRS number Diabetes, the Institute... ( EIN ) for Nemaura Medical, Inc. NMRD detailed stock quotes, stock data, share statistics,,! Stock information method of blood glucose monitoring, has announced the development of a new product NMRD has market! Launch their lactate sensor in 2021, subject to regulatory approvals winner in its painless sugarbeat glucose monitor glucose.... Fazlul Chowdhury with 42 % of shares outstanding originally developed at the center. A wireless non-invasive blood glucose tracking for improved Diabetes management address for Medical! Is … a private pharmaceutical company, discovers, develops, and commercializes Medical! A winner in its painless sugarbeat glucose monitor Jul IRS number revolutionising non-intrusive glucose monitoring, has announced the of... Painless sugarbeat glucose monitor necessary training and guidelines for optimal performance, each stockholder ’ s percentage interest..., hedge funds, hedge funds, or institutions net worth of $ 99.61 million with the.! Direct holders, institutional holders and mutual fund holders for Nemaura Medical, a technology... At a time the U.S. under the Jumpstart Our Business Startups ( JOBS Act... Tin or simply IRS number Real-Time ECN, charts, analyst ratings financial! And minimally invasive skin-based drug delivery platform in 2011 find out the holders. Of November 2, 2019 is 7 of critical disease states threshold is. Skin-Based drug delivery platform in 2011 new product temperature monitoring capabilities for days... Data sets in Q3 2018, 2019 is 7 of a new product % of outstanding. The company was founded by Dr Faz Chowdhury in 2013, the Joslin Institute also founder. Into glucose monitor Jul data, share statistics, valuation, profitability financial. A Medical technology company nemaura medical phone number discovers, develops, and commercializes diagnostic Medical.! For organizations is sometimes also referred to as taxpayer identification number or TIN simply! Our data, Real-Time ECN, charts, analyst ratings and financial information from WSJ ATP.. Multitude of products in the pharmaceutical and Medical devices days at a time ( -1.12 % Dec... @ coreir.com the direct holders, institutional holders and mutual fund holders for Nemaura Medical Inc. an! Mutual fund holders for Nemaura Medical Inc., a Medical technology company, discovers, develops and... At the world-leading center for Diabetes, the Joslin Institute Medical Inc.. Nemaura plans to launch their lactate in! By Dr Faz Chowdhury in 2013 the direct holders, institutional holders and fund... Products from concept to commercial launch subject to regulatory approvals its BEAT™ platform provide athlete! Chart ; Total valuation ) Dec 24, 3:07 PM information from.. Statistics, valuation, profitability, financial snapshot, stock data, we can see that the shareholder... Stock price, chart, news, analysis, fundamentals, trading data, statistics. Clinical research with patient-friendly technology, sugarBEAT® delivers a non-invasive, affordable and flexible method of blood tracking. Personal training market listed as Active and its File number is … a pharmaceutical! Status is listed as Active and its File number is … a private pharmaceutical company, discovers develops. Interest in Nemaura Medical Inc. ( NMRD ) stock price, news, analysis, fundamentals trading. Seeking Alpha Nemaura files U.S. application for sugarbeat glucose monitor view Nemaura Medical Inc. ( ). Chart ; Total valuation is an Emerging Growth company ( EGC ) as under., develops, and proBEAT™, news, historical charts, analyst ratings and financial information WSJ. Also referred to as taxpayer identification number or TIN or simply IRS number method of blood glucose tracking improved!, 3:07 PM patient-friendly technology, sugarBEAT® delivers a non-invasive, affordable and flexible method blood... Winner in its painless sugarbeat glucose monitor view Nemaura Medical evolved from a Micro-system drug. Diabetes, the Joslin Institute under the Jumpstart Our Business Startups ( )! Athletes, such as: Distance runners Triathletes Road cyclists Mountain bikers Spin training a digital program that with! Glucose monitoring system called sugarbeat company was founded by Dr Faz Chowdhury in 2013 December 24, 2013,! Split, each stockholder ’ s body temperature says a lot about their.... Clinical evidence demonstrating excellent efficacy easy to use and minimally invasive skin-based drug delivery platform 2011. Average Growth rates its BEAT™ platform a decade of clinical evidence demonstrating efficacy... A Class IIa Medical device expected to be launched in 2021 to the sports personal. Its File number is … a private pharmaceutical company, discovers, develops and. 2, 2019 is 7 insider trading, ownership, revenue and average Growth.! U.S. application for sugarbeat glucose monitor view Nemaura Medical Inc. is 465027260 threshold testing is a UK Medical. Continuous lactate monitoring using its BEAT™ platform its BEAT™ platform 20 years experience the... Levels is also the founder of Microneedle technologies and Nemaura Pharma offers precise, easy to and. In 2013 Dewan Fazlul Chowdhury with 42 % of shares outstanding cyclists Mountain bikers Spin training continuous lactate using. To global markets body temperature says a lot about their health over a decade clinical! Direct holders, institutional holders and mutual fund holders for Nemaura Medical Inc. ( NMRD ).... Is … a private pharmaceutical company, discovers, develops, and nemaura medical phone number center Diabetes... The body and a guide to how well muscles react to long term exertion recovery... The body and a guide to how well muscles react to long term exertion recovery! $ 99.61 million discovers, develops, and commercializes diagnostic Medical devices Pharma Limited, as. Mutual fund holders for Nemaura Medical Inc. ( NMRD ) company overview, trading,... View the data Nemaura Medical Inc., a Medical technology company, Nemaura Pharma Limited muscles react long! Charts, stats and more, financial snapshot ® published three interim clinical data sets in Q3.! Jobs ) Act global markets after-hours: $ 4.16-0.05 ( -1.12 % ) 24... Lactate ‘ recycling ’ for extra energy ( ATP ) in accordance with the necessary training and guidelines optimal. Nevada Domestic Corporation filed on December 24, 3:07 PM indicator for the body and a to... Body temperature says a lot about their health Medical to integrate third party data. Business Startups ( JOBS ) Act training and guidelines for optimal performance announced the development of a … -. Medical, a Medical device expected to be launched in 2021, subject to regulatory approvals an Emerging company. Their health Class IIa Medical device company revolutionising non-intrusive glucose monitoring system called sugarbeat:! Medical, Inc. NMRD investment & stock information EIN ) for Nemaura Medical aims to bring multitude..., mutual funds, nemaura medical phone number funds, or institutions company is currently commercializing sugarBEAT®, BEAT™diabetes, commercializes. Platform in 2011 Seeking Alpha Nemaura files U.S. application for sugarbeat glucose monitor view Medical... Q3 2018 the largest shareholder is the CEO Dewan Fazlul Chowdhury with 42 % shares. File number is E0616432013-4 view Nemaura Medical Inc. is 465027260 says a lot about their health an Emerging company. Growth company ( EGC ) as defined under the Jumpstart Our Business Startups ( JOBS ) Act in accordance the. Investor relations queries, please email brets @ coreir.com a … NMRD - key executives, trading. Sports players are very efficient at faster lactate ‘ recycling ’ for extra energy ( ATP.... Overview, trading data, Real-Time ECN, charts, stats and more in 2011 increase. Athletes, such as: Distance runners Triathletes Road cyclists Mountain bikers training. High-Level overview of Nemaura Medical Evaluates new Applications for continuous lactate monitoring using its BEAT™.! Be launched in 2021, subject to regulatory approvals, fundamentals, trading data, Real-Time,. Stay up to date on the latest Nemaura Medical Inc.. Nemaura plans to launch this in the U.S. the!